New

Dannce.ai

The AI engine Fit Assessment

Beta

The company will be attending ViVE 2025 Event

Blurb

Building a better way to quantify neurological impairment

HQ Location

Boston (United States)

Founded

2023

Employees

1 - 10

Total funding raised

$2.60M

Last Funding Event

Pre-Seed, $2.60M, November 21, 2024

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M

Developer of a 3-D pose tracking and behavioral quantification platform intended to create digital fingerprints of movement which can be used to identify disease states and drug effects. The company's platform uses a convolutional neural network to analyze the movement of humans and animals for the diagnosis of diseases and the measurement of therapy effectiveness, enabling healthcare providers to improve the standard of care for neurology.